These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

938 related articles for article (PubMed ID: 8382063)

  • 21. Pharmacologic evidence for 5-HT1A receptors associated with human retinal pigment epithelial cells in culture.
    Nash MS; Osborne NN
    Invest Ophthalmol Vis Sci; 1997 Feb; 38(2):510-9. PubMed ID: 9040484
    [TBL] [Abstract][Full Text] [Related]  

  • 22. (1-(2,5-dimethoxy-4 iodophenyl)-2-aminopropane)-induced head-twitches in the rat are mediated by 5-hydroxytryptamine (5-HT) 2A receptors: modulation by novel 5-HT2A/2C antagonists, D1 antagonists and 5-HT1A agonists.
    Schreiber R; Brocco M; Audinot V; Gobert A; Veiga S; Millan MJ
    J Pharmacol Exp Ther; 1995 Apr; 273(1):101-12. PubMed ID: 7714755
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Stimulation and inhibition of adenylyl cyclase by distinct 5-hydroxytryptamine receptors.
    De Vivo M; Maayani S
    Biochem Pharmacol; 1990 Oct; 40(7):1551-8. PubMed ID: 2222510
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects of WAY 100635 and (-)-5-Me-8-OH-DPAT, a novel 5-HT1A receptor antagonist, on 8-OH-DPAT responses.
    Trillat AC; Malagié I; Mathé-Allainmat M; Anmela MC; Jacquot C; Langlois M; Gardier AM
    Eur J Pharmacol; 1998 Apr; 347(1):41-9. PubMed ID: 9650846
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Constitutive G(i2)-dependent activation of adenylyl cyclase type II by the 5-HT1A receptor. Inhibition by anxiolytic partial agonists.
    Albert PR; Sajedi N; Lemonde S; Ghahremani MH
    J Biol Chem; 1999 Dec; 274(50):35469-74. PubMed ID: 10585418
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Differential coupling of 5-HT1A receptors occupied by 5-HT or 8-OH-DPAT to adenylyl cyclase.
    Varrault A; Bockaert J
    Naunyn Schmiedebergs Arch Pharmacol; 1992 Oct; 346(4):367-74. PubMed ID: 1436121
    [TBL] [Abstract][Full Text] [Related]  

  • 27. 8-hydroxy-2-(di-n-propylamino)tetralin-responsive 5-hydroxytryptamine4-like receptor expressed in bovine pulmonary artery smooth muscle cells.
    Becker BN; Gettys TW; Middleton JP; Olsen CL; Albers FJ; Lee SL; Fanburg BL; Raymond JR
    Mol Pharmacol; 1992 Nov; 42(5):817-25. PubMed ID: 1331764
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Contractile effects of 8-hydroxy-2-(di-n-propylamino)tetralin and flesinoxan in human isolated basilar artery.
    Parsons AA; Motevalian M; Whalley ET
    Eur J Pharmacol; 1991 Sep; 202(1):17-23. PubMed ID: 1664803
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Serotonin and the mammalian circadian system: I. In vitro phase shifts by serotonergic agonists and antagonists.
    Prosser RA; Dean RR; Edgar DM; Heller HC; Miller JD
    J Biol Rhythms; 1993; 8(1):1-16. PubMed ID: 8490207
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Characterization of a 5-HT1B receptor on CHO cells: functional responses in the absence of radioligand binding.
    Giles H; Lansdell SJ; Bolofo ML; Wilson HL; Martin GR
    Br J Pharmacol; 1996 Mar; 117(6):1119-26. PubMed ID: 8882605
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pharmacological characterizations of recombinant human 5-HT1D alpha and 5-HT1D beta receptor subtypes coupled to adenylate cyclase inhibition in clonal cell lines: apparent differences in drug intrinsic efficacies between human 5-HT1D subtypes.
    Zgombick JM; Schechter LE; Adham N; Kucharewicz SA; Weinshank RL; Branchek TA
    Naunyn Schmiedebergs Arch Pharmacol; 1996; 354(3):226-36. PubMed ID: 8878051
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Antagonism of 5-hydroxytryptamine1A (5-HT1A) receptor-mediated modulation of adenylate cyclase activity by pindolol and propranolol isomers.
    Oksenberg D; Peroutka SJ
    Biochem Pharmacol; 1988 Sep; 37(18):3429-33. PubMed ID: 2971358
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Serotonin inhibits adenylate cyclase in human platelet membranes.
    Newman ME
    Eur J Pharmacol; 1992 Aug; 226(4):281-5. PubMed ID: 1397059
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Nad-299 antagonises 5-HT-stimulated and spiperone-inhibited [35S]GTPgammaS binding in cloned 5-HT1A receptors.
    Jerning E; Rosqvist S; Mohell N
    J Recept Signal Transduct Res; 2002; 22(1-4):483-95. PubMed ID: 12503636
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pharmacological profile of (-)HT-90B, a novel 5-HT1A receptor agonist/5-HT2 receptor antagonist.
    Uchida H; Inagawa K; Tameda C; Miyauchi T
    Prog Neuropsychopharmacol Biol Psychiatry; 1995 Nov; 19(7):1201-16. PubMed ID: 8787043
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Further assessment of the antagonist properties of the novel and selective 5-HT1A receptor ligands (+)-WAY 100 135 and SDZ 216-525.
    Lanfumey L; Haj-Dahmane S; Hamon M
    Eur J Pharmacol; 1993 Nov; 249(1):25-35. PubMed ID: 8282017
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cloning of another human serotonin receptor (5-HT1F): a fifth 5-HT1 receptor subtype coupled to the inhibition of adenylate cyclase.
    Adham N; Kao HT; Schecter LE; Bard J; Olsen M; Urquhart D; Durkin M; Hartig PR; Weinshank RL; Branchek TA
    Proc Natl Acad Sci U S A; 1993 Jan; 90(2):408-12. PubMed ID: 8380639
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pharmacological characterization of two 5-hydroxytryptamine receptors coupled to adenylate cyclase in guinea pig hippocampal membranes.
    Shenker A; Maayani S; Weinstein H; Green JP
    Mol Pharmacol; 1987 Apr; 31(4):357-67. PubMed ID: 2952874
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Direct activation by dopamine of recombinant human 5-HT1A receptors: comparison with human 5-HT2C and 5-HT3 receptors.
    Oz M; Zhang L; Rotondo A; Sun H; Morales M
    Synapse; 2003 Dec; 50(4):303-13. PubMed ID: 14556235
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The 5-hydroxytryptamine 5-HT1D receptor subtype is negatively coupled to adenylate cyclase in calf substantia nigra.
    Schoeffter P; Waeber C; Palacios JM; Hoyer D
    Naunyn Schmiedebergs Arch Pharmacol; 1988 Jun; 337(6):602-8. PubMed ID: 3216894
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 47.